BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 33667543)

  • 1. Arginine methylation of R81 in Smad6 confines BMP-induced Smad1 signaling.
    Wu J; Chen X; Sehgal P; Zhang T; Jackson-Weaver O; Gou Y; Bautch V; Frenkel B; Sun H; Xu J
    J Biol Chem; 2021; 296():100496. PubMed ID: 33667543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arginine Methylation Initiates BMP-Induced Smad Signaling.
    Xu J; Wang AH; Oses-Prieto J; Makhijani K; Katsuno Y; Pei M; Yan L; Zheng YG; Burlingame A; Brückner K; Derynck R
    Mol Cell; 2013 Jul; 51(1):5-19. PubMed ID: 23747011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arginine methylation of SMAD7 by PRMT1 in TGF-β-induced epithelial-mesenchymal transition and epithelial stem-cell generation.
    Katsuno Y; Qin J; Oses-Prieto J; Wang H; Jackson-Weaver O; Zhang T; Lamouille S; Wu J; Burlingame A; Xu J; Derynck R
    J Biol Chem; 2018 Aug; 293(34):13059-13072. PubMed ID: 29907569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylation of Smad6 by protein arginine N-methyltransferase 1.
    Inamitsu M; Itoh S; Hellman U; Ten Dijke P; Kato M
    FEBS Lett; 2006 Dec; 580(28-29):6603-11. PubMed ID: 17118358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of PRIP (Phospholipase C-Related But Catalytically Inactive Protein) in BMP-Induced Smad Signaling in Osteoblast Differentiation.
    Kotani M; Matsuda M; Murakami A; Takahashi I; Katagiri T; Hirata M
    J Cell Biochem; 2015 Dec; 116(12):2814-23. PubMed ID: 25981537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Smad6 inhibits BMP/Smad1 signaling by specifically competing with the Smad4 tumor suppressor.
    Hata A; Lagna G; Massagué J; Hemmati-Brivanlou A
    Genes Dev; 1998 Jan; 12(2):186-97. PubMed ID: 9436979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone morphogenetic protein activities are enhanced by 3',5'-cyclic adenosine monophosphate through suppression of Smad6 expression in osteoprogenitor cells.
    Sugama R; Koike T; Imai Y; Nomura-Furuwatari C; Takaoka K
    Bone; 2006 Feb; 38(2):206-14. PubMed ID: 16203197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ubc9 promotes the stability of Smad4 and the nuclear accumulation of Smad1 in osteoblast-like Saos-2 cells.
    Shimada K; Suzuki N; Ono Y; Tanaka K; Maeno M; Ito K
    Bone; 2008 May; 42(5):886-93. PubMed ID: 18321803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hoxc8 represses BMP-induced expression of Smad6.
    Kang M; Bok J; Deocaris CC; Park HW; Kim MH
    Mol Cells; 2010 Jan; 29(1):29-33. PubMed ID: 20016939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Smad6 is a Smad1/5-induced smad inhibitor. Characterization of bone morphogenetic protein-responsive element in the mouse Smad6 promoter.
    Ishida W; Hamamoto T; Kusanagi K; Yagi K; Kawabata M; Takehara K; Sampath TK; Kato M; Miyazono K
    J Biol Chem; 2000 Mar; 275(9):6075-9. PubMed ID: 10692396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Focal adhesion kinase activity is required for bone morphogenetic protein--Smad1 signaling and osteoblastic differentiation in murine MC3T3-E1 cells.
    Tamura Y; Takeuchi Y; Suzawa M; Fukumoto S; Kato M; Miyazono K; Fujita T
    J Bone Miner Res; 2001 Oct; 16(10):1772-9. PubMed ID: 11585340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone morphogenetic protein 2 activates Smad6 gene transcription through bone-specific transcription factor Runx2.
    Wang Q; Wei X; Zhu T; Zhang M; Shen R; Xing L; O'Keefe RJ; Chen D
    J Biol Chem; 2007 Apr; 282(14):10742-8. PubMed ID: 17215250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular interaction between Smurf1 WW2 domain and PPXY motifs of Smad1, Smad5, and Smad6--modeling and analysis.
    Sangadala S; Metpally RP; Reddy BV
    J Biomol Struct Dyn; 2007 Aug; 25(1):11-23. PubMed ID: 17676934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Core-binding factor alpha 1 (Cbfa1) induces osteoblastic differentiation of C2C12 cells without interactions with Smad1 and Smad5.
    Nishimura R; Hata K; Harris SE; Ikeda F; Yoneda T
    Bone; 2002 Aug; 31(2):303-12. PubMed ID: 12151083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of the BMP canonical signaling pathway in human optic nerve head tissue and isolated optic nerve head astrocytes and lamina cribrosa cells.
    Zode GS; Clark AF; Wordinger RJ
    Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5058-67. PubMed ID: 17962458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. OAZ regulates bone morphogenetic protein signaling through Smad6 activation.
    Ku M; Howard S; Ni W; Lagna G; Hata A
    J Biol Chem; 2006 Feb; 281(8):5277-87. PubMed ID: 16373339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An atypical canonical bone morphogenetic protein (BMP) signaling pathway regulates Msh homeobox 1 (Msx1) expression during odontogenesis.
    Yang G; Yuan G; Ye W; Cho KW; Chen Y
    J Biol Chem; 2014 Nov; 289(45):31492-502. PubMed ID: 25274628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone mesenchymal stem cell-conditioned medium induces the upregulation of Smad6, which inhibits the BMP-4/Smad1/5/8 signaling pathway.
    Fang H; Song P; Shen C; Liu X; Li H
    Neurol Res; 2016 Nov; 38(11):965-972. PubMed ID: 27636090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of c-Jun NH(2)-terminal kinase 1 increases cellular responsiveness to BMP-2 and decreases binding of inhibitory Smad6 to the type 1 BMP receptor.
    Liu H; Liu Y; Viggeswarapu M; Zheng Z; Titus L; Boden SD
    J Bone Miner Res; 2011 May; 26(5):1122-32. PubMed ID: 21542012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promoting bone morphogenetic protein signaling through negative regulation of inhibitory Smads.
    Itoh F; Asao H; Sugamura K; Heldin CH; ten Dijke P; Itoh S
    EMBO J; 2001 Aug; 20(15):4132-42. PubMed ID: 11483516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.